NCT05088057 2021-10-21
Neoadjuvant Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer
Jilin University
Phase 2 Unknown
Clinical Trials
3 trialsNCT01642771 2017-04-19
Comparative Study on Two Post-operative Adjuvant Chemotherapy Regimens for Treating Triple-negative Breast Cancer
China Breast Cancer Clinical Study Group
Phase 3 Unknown
NCT02685657 2016-02-22
Neoadjuvant Chemotherapy Docetaxel With or Without SELUMETINIB in Patients With Triple Negative Breast Cancer
Russian Academy of Medical Sciences
Phase 2 Unknown